A qualitative exploration of family members’ perspectives on reducing and discontinuing antipsychotic medication

References

• Bjornestad, J., Davidson, L., Joa, I., Larsen, T. K., Hegelstad, V., Langeveld, J., Veseth, M., Melle, I., Johannessen, J., & Bronnick, K. (2017). Antipsychotic treatment: Experiences of fully recovered service users. Journal of Mental Health (Abingdon, England), 26(3), 264–270. https://doi.org/10.1080/09638237.2017.1294735
   PubMed Web of Science ®Google Scholar
• Bradley, E., & Green, D. (2018). Involved, inputting or informing: "Shared" decision making in adult mental health care. Health Expectations: An International Journal of Public Participation in Health Care and Health Policy, 21(1), 192–200. https://doi.org/10.1111/hex.12601
   PubMed Web of Science ®Google Scholar
• Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
   Google Scholar
• Chouinard, G., & Jones, B. D. (1980). Neuroleptic-induced supersensitivity psychosis: Clinical and pharmacologic characteristics. The American Journal of Psychiatry, 137(1), 16–21. https://doi.org/10.1176/ajp.135.11.1409.
   PubMed Web of Science ®Google Scholar
• Cooper, R. E., Hanratty, É., Morant, N., & Moncrieff, J. (2019). Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation. Plos One, 14(6), e0218711. https://doi.org/10.1371/journal.pone.0218711
   PubMed Web of Science ®Google Scholar
• Deane, F. P., McAlpine, E., Byrne, M. K., Davis, E. L., & Mortimer, C. (2018). Are carer attitudes toward medications related to self-reported medication adherence amongst people with mental illness? Psychiatry Research, 260, 158–163. https://doi.org/10.1016/j.psychres.2017.11.055
   PubMed Web of Science ®Google Scholar
• Geyt, G. L., Awenat, Y., Tai, S., & Haddock, G. (2016). Personal accounts of discontinuing neuroleptic medication for psychosis. Qualitative Health Research, 27(4), 559–572. https://doi.org/10.1177/1049732316634047
   PubMed Web of Science ®Google Scholar
• Gray, R., & Deane, K. (2016). What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis. Journal of Psychiatric and Mental Health Nursing, 23(2), 108–115. https://doi.org/10.1111/jpm.12288
   PubMed Web of Science ®Google Scholar
• Gupta, S., Isherwood, G., Jones, K., & Van Impe, K. (2015). Assessing health status in informal schizophrenia caregivers compared with health status in non-caregivers and caregivers of other conditions. BioMed Central Psychiatry, 15(1), 1–11. https://doi.org/10.1186/s12888-015-0547-1
   PubMedGoogle Scholar
• Gutiérrez-Maldonado, J., Caqueo-Urízar, A., & Kavanagh, D. J. (2005). Burden of care and general health in families of patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 40(11), 899–904. https://doi.org/10.1007/s00127-005-0963-5
   PubMed Web of Science ®Google Scholar
• Harrow, M., Jobe, T. H., & Faull, R. N. (2012). Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychological Medicine, 42(10), 1–11. https://doi.org/10.1017/S0033291712000220.
   PubMed Web of Science ®Google Scholar
• Hannan, R. (2013). The Triangle of Care: carers included. Journal of Public Mental Health, 12(3), 171–172. https://doi.org/10.1108/JPMH-06-2013-0042
   Google Scholar
• Hayes, L., Hawthorne, G., Farhall, J., O'Hanlon, B., & Harvey, C. (2015). Quality of life and social isolation among caregivers of adults with schizophrenia: Policy and outcomes. Community Mental Health Journal, 51(5), 591–597. https://doi.org/10.1007/s10597-015-9848-6
   PubMed Web of Science ®Google Scholar
• Katz, S., Goldblatt, H., Hasson-Ohayon, I., & Roe, D. (2019). Retrospective accounts of the process of using and discontinuing psychiatric medication. Qualitative Health Research, 29(2), 198–210. https://doi.org/10.1177/1049732318793418
   PubMed Web of Science ®Google Scholar
• Kirkbride, J. B., Errazuriz, A., Croudace, T. J., Morgan, C., Jackson, D., Boydell, J., Murray, R. M., & Jones, P. B. (2012). Incidence of schizophrenia and other psychoses in England, 1950–2009: A systematic review and meta-analyses. PLoS ONE, 7(3), e31660. https://doi.org/10.1371/journal.pone.0031660
   PubMed Web of Science ®Google Scholar
• Landolt, K., Rössler, W., Ajdacic-Gross, V., Derks, E. M., Libiger, J., Kahn, R. S. & Fleischhacker, W. W. (2016). Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST). Schizophrenia Research, 172(1–3), 145–151. https://doi.org/10.1016/j.schres.2016.01.046
   PubMed Web of Science ®Google Scholar
• Larsen-Barr, M., & Seymour, F. (2021). Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication. Therapeutic Advances in Psychopharmacology, 11, 2045125321989133. https://doi.org/10.1177/2045125321989133
   Web of Science ®Google Scholar
• Larsen-Barr, M., Seymour, F., Read, J., & Gibson, K. (2018). Attempting to stop antipsychotic medication: Success, supports, and efforts to cope. Social Psychiatry and Psychiatric Epidemiology, 53(7), 745–756. https://doi.org/10.1007/s00127-018-1518-x
   PubMed Web of Science ®Google Scholar
• Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012). Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis. The Lancet, 379(9831), 2063–2071. https://doi.org/10.1016/S0140-6736(12)60239-6
   PubMed Web of Science ®Google Scholar
• Magliano, L., Fiorillo, A., De Rosa, C., Malangone, C., & Maj, M. (2005). Family burden in long-term diseases: A comparative study in schizophrenia vs. physical disorders. Social Science & Medicine (1982), 61(2), 313–322. https://doi.org/10.1016/j.socscimed.2004.11.064
   PubMed Web of Science ®Google Scholar
• Moncrieff, J., Lewis, G., Freemantle, N., Johnson, S., Barnes, T. R. E., Morant, N., Pinfold, V., Hunter, R., Kent, L. J., Smith, R., Darton, K., Horne, R., Crellin, N. E., Cooper, R. E., Marston, L., & Priebe, S. (2019). Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: The RADAR trial (Research into antipsychotic discontinuation and reduction). British Medical Journal Open, 9(11), e030912. https://doi.org/10.1136/bmjopen-2019-030912
   PubMed Web of Science ®Google Scholar
• Morant, N., Azam, K., Johnson, S., & Moncrieff, J. (2018). The least worst option: User experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. Journal of Mental Health (Abingdon, England), 27(4), 322–328. https://doi.org/10.1080/09638237.2017.1370637
   PubMed Web of Science ®Google Scholar
• Morant, N., Kaminskiy, E., & Ramon, S. (2016). Shared decision making for psychiatric medication management: Beyond the micro-social. Health Expectations: An International Journal of Public Participation in Health Care and Health Policy, 19(5), 1002–1014. https://doi.org/10.1111/hex.12392
   PubMed Web of Science ®Google Scholar
• Morrison, A. P., Hutton, P., Shiers, D., & Turkington, D. (2012). Antipsychotics: Is it time to introduce patient choice? The British Journal of Psychiatry: The Journal of Mental Science, 201(2), 83–84. https://doi.org/10.1192/bjp.bp.112.112110
   PubMed Web of Science ®Google Scholar
• Morrison, P., & Stomski, N. (2017). Experiences of family carers for persons using antipsychotic medication. Australian and New Zealand Journal of Family Therapy, 38(3), 498–513. https://doi.org/10.1002/anzf.1228
   Web of Science ®Google Scholar
• Murray, R., Quattrone, D., Natesan, S., Van Os, J., Nordentoft, M., Howes, O., Forti, M., & Taylor, D. (2016). Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? The British Journal of Psychiatry: The Journal of Mental Science, 209(5), 361–365. https://doi.org/10.1192/bjp.bp.116.182683
   PubMed Web of Science ®Google Scholar
• NICE (2014). Psychosis and schizophrenia in adults: prevention and management and management Clinical guideline, National Institute for Health and Care Excellence. 5. https://doi.org/10.1002/path.2386
   Google Scholar
• O'Keeffe, D., Hannigan, A., Doyle, R., Kinsella, A., Sheridan, A., Kelly, A., Madigan, K., Lawlor, E., & Clarke, M. (2019). The iHOPE-20 study: Relationships between and prospective predictors of remission, clinical recovery, personal recovery and resilience 20 years on from a first episode psychosis. The Australian and New Zealand Journal of Psychiatry, 53(11), 1080–1092. https://doi.org/10.1177/0004867419827648
   PubMed Web of Science ®Google Scholar
• Onwumere, J., Shiers, D., & Chew-Graham, C. (2016). Understanding the needs of carers of people with psychosis in primary care. The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 66(649), 400–401. https://doi.org/10.3399/bjgp16X686209
   PubMed Web of Science ®Google Scholar
• Rappaport, M., Hopkins, H. K., Hall, K., Belleza, T., & Silverman, J. (1978). Are there schizophrenics for whom drugs may be unnecessary or contraindicated? International Pharmacopsychiatry, 13(2), 100–111. https://doi.org/10.1159/000468327
   PubMedGoogle Scholar
• Rogers, A., Day, J. C., Williams, B., Randall, F., Wood, P., Healy, D., & Bentall, R. P. (1998). The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. Social Science & Medicine (1982), 47(9), 1313–1323. https://doi.org/10.1016/S0277-9536(98)00209-3
   PubMed Web of Science ®Google Scholar
• Smith, R. C., Leucht, S., & Davis, J. M. (2019). Maximizing response to first-line antipsychotics in schizophrenia: A review focused on finding from meta-analysis. Psychopharmacology, 236(2), 545–559. https://doi.org/10.1007/s00213-018-5133-z
   PubMed Web of Science ®Google Scholar
• Smith, L. M., Onwumere, J., Craig, T., & Kuipers, E. (2019). Role of poor sleep in determining distress in caregivers of individuals with early psychosis. Early Intervention in Psychiatry, 13(3), 613–617. https://doi.org/10.1111/eip.12538
   PubMed Web of Science ®Google Scholar
• Smith, L., Onwumere, J., Craig, T., McManus, S., Bebbington, P., & Kuipers, E. (2014). Mental and physical illness in caregivers: Results from an English national survey sample. The British Journal of Psychiatry: The Journal of Mental Science, 205(3), 197–203. https://doi.org/10.1192/bjp.bp.112.125369
   PubMed Web of Science ®Google Scholar
• Thompson, J., Stansfeld, J. L., Cooper, R. E., Morant, N., Crellin, N., & Moncrieff, J. (2020). Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: A systematic review and thematic synthesis of qualitative data. Social Psychiatry and Psychiatric Epidemiology, 55(2), 151–164. https://doi.org/10.1007/s00127-019-01819-2
   PubMed Web of Science ®Google Scholar
• Wade, M., Tai, S., Awenat, Y., & Haddock, G. (2017). A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis. Clinical Psychology Review, 51, 75–95. https://doi.org/10.1016/j.cpr.2016.10.009
   PubMed Web of Science ®Google Scholar
• Waheed, W., Hughes-Morley, A., Woodham, A., Allen, G., & Bower, P. (2015). Overcoming barriers to recruiting ethnic minorities to mental health research: a typology of recruitment strategies. BMC psychiatry, 15(1), 1–11. https://doi.org/10.1186/s12888-015-0484-z
   Google Scholar
• Wainwright, L. D., Glentworth, D., Haddock, G., Bentley, R., & Lobban, F. (2015). What do relatives experience when supporting someone in early psychosis? Psychology and Psychotherapy, 88(1), 105–119. https://doi.org/10.1111/papt.12024
   PubMed Web of Science ®Google Scholar
• Wallace, M. (1994). Schizophrenia‐a national emergency: Preliminary observations on SANELINE. Acta Psychiatrica Scandinavica, 89(s380), 33–35. https://doi.org/10.1111/j.1600-0447.1994.tb05829.x
   Google Scholar
• Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: Long-term follow-up of a 2-year randomized clinical trial. Journal of American Medical Association Psychiatry, 70(9), 913–920. https://doi.org/10.1001/jamapsychiatry.2013.19
   Google Scholar